Pi Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $19.7M
Latest Deal Amount
  • Investors
  • 12

Pi Therapeutics General Information

Description

Operator of a preclinical-stage pharmaceutical company designed to develop protein degradation modulators for the treatment of cancer. The company's pharmaceutical offers a unique approach to the preferential targeting of cancer cells as well as develop a proprietary cancer drug that inhibits the proteasome-interacting protein Rpn13, enabling people to access proper treatment of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 2 Ilan Ramon street
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 29-May-2019 $19.7M 000.00 00000 Completed Generating Revenue
3. Early Stage VC Completed Startup
2. Accelerator/Incubator 01-Mar-2015 Completed Startup
1. Accelerator/Incubator 12-Dec-2014 Completed Startup
To view Pi Therapeutics’s complete valuation and funding history, request access »

Pi Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Ori Kalid Ph.D Co-Founder & Chief Executive Officer
Uzi Izhaky Acting Chief Financial Officer
To view Pi Therapeutics’s complete executive team members history, request access »

Pi Therapeutics Board Members (8)

Name Representing Role Since
Avnur Zafi Pi Therapeutics Board Member 000 0000
Habib Michel Pi Therapeutics Board Member 000 0000
Merav Kaye Self Board Member 000 0000
Ohad Hammer Self Board Member 000 0000
Pini Orbach Ph.D Arkin Bio-Ventures Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Pi Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arkin Bio-Ventures Venture Capital Minority 000 0000 000000 0
Consensus Business Group Asset Manager Minority 000 0000 000000 0
GF Securities Investment Bank Minority 000 0000 000000 0
Pontifax Venture Capital Venture Capital Minority 000 0000 000000 0
Quark Venture Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »